Literature DB >> 16173886

Reactivity to alcohol cues: isolating the role of perceived availability.

James MacKillop1, Stephen A Lisman.   

Abstract

Perceived availability of a substance has been proposed to play a role in cue reactivity by both traditional classical conditioning models and S. T. Tiffany's (1990) cognitive processing model (CPM) of substance use. This study investigated the role of availability information on alcohol cue reactivity. Subjects were 134 heavy drinkers in a 2 x 2 between-subjects design, crossing cues (alcohol vs. neutral) and availability information (availability vs. unavailability). The results indicated significant main effects for cue type, with alcohol cues eliciting greater reactivity on multiple measures, and an interaction effect on the Alcohol Urge Questionnaire (M. J. Bohn, D. D. Krahn, & B. B. Staehler, 1995), such that exposure to alcohol cues in conjunction with unavailability information elicited a greater urge. This was largely a result of changes in self-reported craving and was interpreted as consistent with the CPM. Alternative methodologies and limitations are discussed. ((c) 2005 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16173886     DOI: 10.1037/1064-1297.13.3.229

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  15 in total

1.  Is talk "cheap"? An initial investigation of the equivalence of alcohol purchase task performance for hypothetical and actual rewards.

Authors:  Michael T Amlung; John Acker; Monika K Stojek; James G Murphy; James MacKillop
Journal:  Alcohol Clin Exp Res       Date:  2011-10-21       Impact factor: 3.455

2.  Behavioral economic analysis of cue-elicited craving for alcohol.

Authors:  James MacKillop; Sean O'Hagen; Stephen A Lisman; James G Murphy; Lara A Ray; Jennifer W Tidey; John E McGeary; Peter M Monti
Journal:  Addiction       Date:  2010-07-12       Impact factor: 6.526

3.  Factor Structure Validation of the Alcohol Dependence Scale in a Heavy Drinking College Sample.

Authors:  Cara M Murphy; James Mackillop
Journal:  J Psychopathol Behav Assess       Date:  2011-07-01

Review 4.  Evidence for incentive salience sensitization as a pathway to alcohol use disorder.

Authors:  Roberto U Cofresí; Bruce D Bartholow; Thomas M Piasecki
Journal:  Neurosci Biobehav Rev       Date:  2019-10-28       Impact factor: 8.989

5.  Effect of the CRF1-receptor antagonist pexacerfont on stress-induced eating and food craving.

Authors:  David H Epstein; Ashley P Kennedy; Melody Furnari; Markus Heilig; Yavin Shaham; Karran A Phillips; Kenzie L Preston
Journal:  Psychopharmacology (Berl)       Date:  2016-09-05       Impact factor: 4.530

6.  Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedure.

Authors:  Marc I Kruse; Alexander J Radnovich; Raj K Kalapatapu; Nicole Mehdiyoun; R Andrew Chambers; Dena Davidson
Journal:  J Stud Alcohol Drugs       Date:  2012-03       Impact factor: 2.582

7.  Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial.

Authors:  Robert Miranda; Hayley Treloar Padovano; Joshua C Gray; Stephanie E Wemm; Alexander Blanchard
Journal:  Addict Behav       Date:  2018-01-10       Impact factor: 3.913

8.  Clarifying the neural basis for incentive salience of tobacco cues in smokers.

Authors:  Joshua C Gray; Michael T Amlung; John Acker; Lawrence H Sweet; Courtney L Brown; James MacKillop
Journal:  Psychiatry Res       Date:  2014-06-19       Impact factor: 3.222

9.  Interrelationships among impulsive personality traits, food addiction, and Body Mass Index.

Authors:  Cara M Murphy; Monika K Stojek; James MacKillop
Journal:  Appetite       Date:  2014-02       Impact factor: 3.868

10.  Craving as an alcohol use disorder symptom in DSM-5: an empirical examination in a treatment-seeking sample.

Authors:  Cara M Murphy; Monika K Stojek; Lauren R Few; Alex O Rothbaum; James Mackillop
Journal:  Exp Clin Psychopharmacol       Date:  2014-02       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.